Clinical Trial Update: Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal Men [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of oral fispemifene for sexual dysfunction in men with secondary hypogonadism; the status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Hypogonadism
• Sexual Dysfunction

Drugs mentioned

• Fispemifene

Snippet

Sponsor: NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) | Conditions: Secondary Hypogonadism, Sexual Dysfunction | Phase 2 | Status: UNKNOWN